Basic information Safety Supplier Related

ZONISAMIDE-13C2-15N

Basic information Safety Supplier Related

ZONISAMIDE-13C2-15N Basic information

Product Name:
ZONISAMIDE-13C2-15N
Synonyms:
  • ZONISAMIDE-13C2-15N
  • 13C2,15N]-Zonisamide
CAS:
1188265-58-8
MF:
C8H8N2O3S
MW:
215.25
Mol File:
Mol File
More
Less

ZONISAMIDE-13C2-15N Chemical Properties

Melting point:
158 - 160°C
storage temp. 
Refrigerator
solubility 
DMSO (Sparingly), Methanol (Slightly)
form 
Solid
color 
Off-White to Light Yellow
More
Less

ZONISAMIDE-13C2-15N Usage And Synthesis

Description

Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide is an antiepileptic agent. It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml. In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium current. Zonisamide inhibits H. pylori recombinant carbonic anhydrase (CA) and the human CA isoforms I, II, and V with Ki values of 218, 56, 35, and 21 nM, respectively. In mice, it has anticonvulsant activity against maximal electroshock seizure (MES) and pentylenetetrazole-induced maximal, but not minimal, seizures (ED50s = 19.6, 9.3, and >500 mg/kg, respectively). Zonisamide (40 mg/kg, p.o.) prevents MPTP-induced decreases in the levels of dopamine , but not homovanillic acid (HVA; ) or dihydroxyphenyl acetic acid (DOPAC; ), and increases MPTP-induced decreases in the dopamine turnover rate in mouse striatum in a model of Parkinson''s disease. Formulations containing zonisamide have been used in the treatment of partial seizures in adults with epilepsy.

Uses

Zonisamide-13C2-15N is the labeled analogue of Zonisamide (Z700000), a sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation for potential therapeutic use as an antiepileptic drug. Anticonvulsant.

ZONISAMIDE-13C2-15NSupplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Cato Research Chemicals Inc.
Tel
020-81960175
Email
min.he@cato-chem.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Shanghai QianYan Bio-technology Co., Ltd
Tel
02781293128
Email
orders@biochemsafebuy.com
Hubei Yangxin Medical Technology Co., Ltd.
Tel
15374522761
Email
3003392093@qq.com
More
Less

ZONISAMIDE-13C2-15N(1188265-58-8)Related Product Information